These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26498163)

  • 21. Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insights from a large multicentre registry.
    Wörmann J; Strik M; Jurisic S; Stout K; Elrefai M; Becher N; Schaer B; van Stipdonk A; Srinivasan NT; Ploux S; Breitenstein A; Kron J; Roberts PR; Toennis T; Linz D; Dulai R; Hermes-Laufer J; Koneru J; Erküner Ö; Dittrich S; van den Bruck JH; Schipper JH; Sultan A; Rosenberger KD; Steven D; Lüker J
    Europace; 2024 Jun; 26(6):. PubMed ID: 38861398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased inappropriate shocks with new generation ICDs in children and patients with congenital heart disease.
    Goldstein SA; LaPage MJ; Dechert BE; Serwer GA; Yu S; Lowery RE; Bradley DJ
    Congenit Heart Dis; 2018 May; 13(3):413-418. PubMed ID: 29372620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies.
    Garnreiter JM; Pilcher TA; Etheridge SP; Saarel EV
    Heart Rhythm; 2015 May; 12(5):937-42. PubMed ID: 25620047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead.
    Kallinen LM; Hauser RG; Lee KW; Almquist AK; Katsiyiannis WT; Tang CY; Melby DP; Gornick CC
    Heart Rhythm; 2008 Jun; 5(6):775-9. PubMed ID: 18534361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures.
    Kallinen LM; Hauser RG; Tang C; Melby DP; Almquist AK; Katsiyiannis WT; Gornick CC
    Heart Rhythm; 2010 Aug; 7(8):1048-55. PubMed ID: 20493965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
    Sacher F; Probst V; Bessouet M; Wright M; Maluski A; Abbey S; Bordachar P; Deplagne A; Ploux S; Lande G; Jaïs P; Hocini M; Haïssaguerre M; Le Marec H; Clémenty J
    Europace; 2009 Apr; 11(4):489-94. PubMed ID: 19218576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remote monitoring of implantable devices: Should we continue to ignore it?
    Bertini M; Marcantoni L; Toselli T; Ferrari R
    Int J Cardiol; 2016 Jan; 202():368-77. PubMed ID: 26432486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remote monitoring of patients with implantable cardioverter-defibrillators: can results from large clinical trials be transposed to clinical practice?
    Morichau-Beauchant T; Boulé S; Guédon-Moreau L; Finat L; Botcherby EJ; Périer MC; Salleron J; Guibout C; Marquié C; Klug D; Kouakam C; Wissocque L; Brigadeau F; Lacroix D; Kacet S
    Arch Cardiovasc Dis; 2014 Dec; 107(12):664-71. PubMed ID: 25241223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture.
    Chinushi M; Hosaka Y; Ikarashi N; Iijima K; Furushima H; Aizawa Y
    Europace; 2008 Jun; 10(6):738-40. PubMed ID: 18390874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.
    Theuns DAMJ; Brouwer TF; Jones PW; Allavatam V; Donnelley S; Auricchio A; Knops RE; Burke MC
    Heart Rhythm; 2018 Oct; 15(10):1515-1522. PubMed ID: 29758404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area.
    Callum K; Graune C; Bowman E; Molden E; Leslie SJ
    World J Cardiol; 2021 Mar; 13(3):46-54. PubMed ID: 33791078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Sachanandani H; Ellenbogen KA
    Circulation; 2010 Oct; 122(15):1449-55. PubMed ID: 20876433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.
    Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F
    Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
    Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
    J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An unusual cause of inappropriate shocks delivered by an implantable cardioverter defibrillator.
    Baldauf B; Lau EW; Giaccardi M; Bonnemeier H
    BMC Cardiovasc Disord; 2024 Jul; 24(1):380. PubMed ID: 39039491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of the failure rates among 3 implantable defibrillator leads.
    van Malderen SC; Szili-Torok T; Yap SC; Hoeks SE; Zijlstra F; Theuns DA
    Heart Rhythm; 2016 Dec; 13(12):2299-2305. PubMed ID: 27496586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.
    Irfan G; Czapla J; Saitoh Y; Ciconte G; Mugnai G; Conte G; Hunuk B; Velagic V; Stroker E; Chierchia GB; Nijs J; La Meir M; Wellens F; Brugada P; De Asmundis C
    Europace; 2017 Jan; 19(1):81-87. PubMed ID: 26893495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.